[Research on function of Feilike Mixture in stopping cough, eliminating phlegm and relieving asthma based on animal experiments and network pharmacology].

Zhongguo Zhong Yao Za Zhi

Institute of Basic Medicine, Xiyuan Hospital, China Academy of Chinese Medical Sciences/Beijing Key Laboratory of Pharmacology of Traditional Chinese Medicine Beijing 100091, China.

Published: July 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

This study observed the pharmacological effects of Feilike Mixture(FLKM) in stopping cough, eliminating phlegm, and relieving asthma through animal experiments, and explored its mechanism using network pharmacology. The antitussive effect was detected by citric acid-induced guinea pig cough model, the expectorant effect by mouse phenol red excretion experiment and lipopolysaccharide-induced mucus hypersecretion rat model, and the antiasthmatic effect by histamine phosphate-induced guinea pig asthma model. The chemical components of FLKM were collected by TCMSP, TCMID, TCMIP, and BATMAN-TCM databases and literature search, and the potential active components were screened through ADMETlab 2.0. The targets of FLKM were obtained by STITCH, SwissTargetPrediction, and TCMSP, and the symptom targets of cough, phlegm, and asthma were acquired through SymMap database. After taking the intersection of FLKM targets and symptom targets, this study used the OECloud tool to perform Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes(KEGG) enrichment analysis. RESULTS:: demonstrated that FLKM 0.43-1.74 g·kg~(-1) reduced the number of coughs in guinea pigs within 3 min(P<0.05, P<0.01), and FLKM 6-12 g·kg~(-1) increased the tracheal phenol red excretion in mice(P<0.01). Moreover, FLKM 2-8 g·kg~(-1) inhibited the number of goblet cells(P<0.05, P<0.01), and FLKM 7-11.2 g·kg~(-1) prolonged the incubation period of asthma(P<0.05). A total of 115 potential active components and 910 targets of FLKM were obtained through network pharmacological analysis. FLKM had 27, 12, and 7 targets for stopping cough, eliminating phlegm, and relieving asthma, respectively. The GO and KEGG enrichment analysis found that there were commonalities and characteristics, among which cytokine-cytokine receptor interaction and infectious disease-related signaling pathway were shared. FLKM has a good effect of stopping cough, eliminating phlegm, and relieving asthma through animal experiments and network pharmacology.

Download full-text PDF

Source
http://dx.doi.org/10.19540/j.cnki.cjcmm.20220310.401DOI Listing

Publication Analysis

Top Keywords

stopping cough
16
cough eliminating
16
eliminating phlegm
16
phlegm relieving
16
relieving asthma
16
animal experiments
12
flkm
10
experiments network
8
asthma animal
8
network pharmacology
8

Similar Publications

Background: Painless gastroscopy is preferred by both patients and physicians, as it minimizes discomfort during the procedure. Alfentanil, a short-acting opioid analgesic, possesses pharmacological properties that make it suitable for inducing analgesia during gastroscopy. However, research on the optimal dosage of alfentanil when used in combination with propofol for gastroscopy is limited.

View Article and Find Full Text PDF

A 64-year-old man, with a history of hepatocellular carcinoma and long-term oral lenvatinib treatment, was hospitalised in our institution twice due to 'cough'. During hospitalisation, the patient underwent multiple bronchoscopies, with lavage fluid sent for pathogen testing, which returned negative results. Finally, was detected via next-generation sequencing (NGS).

View Article and Find Full Text PDF

Aseptic meningitis (AM) is characterized by clinical manifestations and laboratory findings indicative of meningeal inflammation, without detectable bacterial pathogens in routine cultures. Drug-induced aseptic meningitis (DIAM) is a rare but important etiology. It has been associated with certain drugs, including intravenous immunoglobulin, antiepileptic drugs, monoclonal antibodies, and antibiotics.

View Article and Find Full Text PDF

Introduction: Anaplastic lymphoma kinase (ALK) inhibitors have been approved for non-small cell lung cancer (NSCLC) patients with ALK-rearrangement. Ceritinib, a clinically approved ALK inhibitor, is associated with some adverse reactions, including organizing pneumonia (OP). However, few cases of ceritinib-induced OP have been reported to date.

View Article and Find Full Text PDF

Immune-checkpoint inhibitors (ICIs) have transformed cancer therapy, but immune-related adverse events (irAEs) remain a major concern. Tislelizumab-a humanised anti-PD-1 monoclonal antibody-has a favourable safety profile; thus, severe hypersensitivity reactions are rarely reported. A 61-year-old male patient was admitted in October 2023 with complaints of intermittent cough and dyspnoea for 1 year, aggravation accompanied by fatigue and bloody sputum for more than 20 days.

View Article and Find Full Text PDF